Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bonviva for post-menopausal osteoporosis
NCT00048074Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2002
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of ibandronic acid in postmenopausal osteoporosis, sponsored by Roche. Started Jun 2002; status: completed.
02
Drugs
ibandronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00048074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048074.